Healthscore 697·7 metrosupdated 11m ago
FDA Scientists Push Back Against Easier Access to Unproven Peptide Drugs
Most FDA scientists oppose a plan by Health Secretary Robert F. Kennedy Jr. to ease access to unproven peptide drugs, warning it could undermine public health. The policy, currently under White House review, would allow specialty pharmacies to sell certain peptides without FDA oversight.
Where it's breaking
Local coverage
FDA scientists opposed the Trump administration’s effort to ease peptides access
FDA scientists opposed the Trump administration’s effort to ease peptides access
FDA scientists opposed the Trump administration’s effort to ease peptides access
RFK Jr. eases access to unproven peptides despite opposition from FDA scientists
FDA scientists opposed the Trump administration’s effort to ease peptides access
FDA scientists opposed the Trump administration’s effort to ease peptides access
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
- T2The Virginian-Pilot
- T2Daily Press
- T2Capital Gazette
- T2Baltimore Sun
- T2Philadelphia Inquirer
- T3Daily Local News (Chester County)
- T3Delaware County Daily Times
- T3Oakland Press
- T3Macomb Daily
- T2Sun Sentinel (South Florida)
- T2Pasadena Star-News
- T2Orange County Register
- T2San Bernardino Sun
- T2Lowell Sun
- T2WDIV (Local 4 / NBC Detroit)
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.